A novel dihydroacridine derivative targets epidermal growth factor receptor-expressing cancer cells in vitro and in vivo

• Principais autores: Anna Epishkina (Autor), Viktoria Pakina (Autor), Ekaterina Kutorkina (Autor), Evgeniia Bogoslovskaya (Autor), Oksana Tumutolova (Autor), Matvey Tolstov (Autor), Aleksandra Igrunkova (Autor), Ilya Fedoseikin (Autor), Ekaterina Blinova (Autor), Elena Semeleva (Autor), Dmitrii Blinov (Autor)
• Formato: Livro
• Publicado em: Wolters Kluwer Medknow Publications, 2024-05-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Small molecules are considered a source of novel medicines targeting carcinogenic intracellular pathways including epidermal growth factor receptor (EGFR) signaling. The main goal of the study is to assess whether LHT-17-19 could be considered an effective target molecule against EGFR-expressing tum...